Powered by ZigaForm version 3.9.8.8

Public Alert No. 009/2020 – Alert on Falsified Proximexa Suspension 125mg/5ml Lot Number C830116 Circulating in Nigeria.

September 8, 2020,

The National Agency for Food and Drug Administration and Control has been informed by Allen & Hanburys (A&H) Pharmaceutical Nigeria Limited on the circulation of falsified Proximexa Suspension (Cefuroxime Axetil 125mg/5ml) Lot Number C830116 in retail outlets in Nigeria.

The falsified Proximexa Suspension 125mg /5ml Lot number C830116 is labelled with fictitious MANFD SEP 2019 and EXP SEP 2022.

The details of the falsified Proximexa Suspension 125mg /5ml are as follows:

Product Name Proximexa Suspension 125mg /5ml
Stated Manufacturer Glaxo operations UK Ltd
Lot C830116
MANFD SEP 2019
EXP SEP 2022

The package label of the falsified Proximexa Suspension 125mg /5ml showing MANFD: SEP 2019 and EXP: 2022 is below

Genuine Proximexa Suspension 125mg /5ml (Cefuroxime Axetil125mg/5ml) Batch Number C830116 manufactured by Glaxo operations UK Ltd has manufacturing date SEP 2017 and Expiry date SEP 2019. The genuine Proximexa Suspension 125mg /5ml Batch Number C830116 expired in SEP 2019.

The genuine Proximexa Suspension 125mg /5ml manufactured by Glaxo operations UK Ltd is registered by NAFDAC with NAFDAC Reg. No: A4-6143

Genuine Proximexa Suspension 125mg /5ml is an antibiotic used to treat a wide variety of bacterial infections including bronchitis, urinary tract infections and pneumonia.

Glaxo operations UK Ltd has confirmed that they did not manufacture the affected falsified Proximexa Suspension 125mg /5ml.

All importers, wholesalers and retailers are implored to desist from illegal importation, distribution and sale of the falsified Proximexa Suspension 125mg /5ml

Surveillance has been strengthened by NAFDAC at all ports of entry to prevent illegal importation of the falsified Proximexa Suspension 125mg /5ml

The Agency has heightened surveillance in the thirty-six States and the Federal Capital Territory, Abuja to prevent distribution and sale of falsified Proximexa Suspension 125mg /5ml

Health care providers and other members of the public are advised to be vigilant and contact the nearest NAFDAC office with any information on the falsified Proximexa Suspension 125mg /5ml

Anybody in possession of the falsified Proximexa Suspension 125mg /5ml should submit it to the nearest NAFDAC office.

Consumers are advised to report adverse events related to use medicines to the nearest NAFDAC office, 0800-1-NAFDAC (0800-1-623322) TOLL FREE from all networks or via pharmacovigilance@nafdac.gov.ng

 

NAFDAC……..Customer-focused, Agency-minded!!!

Signed Management